KYNB
Kyntra Bio, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$8.55
+0.71%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.14x
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.15x
- PEG TTM
- —
- Price / book
- -1.15x
- Price / sales
- 7.50x
- Price / cash flow
- -0.91x
Enterprise value
- Enterprise value
- -$34.7M
- EV / sales
- -7.52x
- EV / EBITDA
- 0.37x
- EV / EBIT
- 0.68x
- Market cap
- $34.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026